Clinical Features and Treatment Results of Conjunctival Lymphoproliferative Lesions.
- Author:
Dae Won LIM
1
;
Seong Kyu IM
;
Kyung Chul YOON
Author Information
1. Department of Ophthalmology Chonnam National University Medical School and Hospital, Gwang-Ju, Korea. kcyoon@chonnam.ac.kr
- Publication Type:Original Article
- Keywords:
Conjunctival lymphoproliferative lesions;
MALT-lymphoma;
Recurrence
- MeSH:
Classification;
Drug Therapy;
Humans;
Hyperplasia;
Leukemia, Lymphocytic, Chronic, B-Cell;
Lymphoma;
Prognosis;
Radiotherapy;
Recurrence;
Retrospective Studies
- From:Journal of the Korean Ophthalmological Society
2004;45(11):1820-1826
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: To investigate the clinical features of conjunctival lymphoproliferative lesions and associated systemic lymphoma, and to determine the recurrence rate and prognosis according to treatment methods. METHODS: Eighteen patients with conjunctival lymphoproliferative lesions were followed up. We retrospectively analyzed data for clinical symptoms, anatomical location, histological type, associated systemic lymphoma, and treatment results. RESULTS: Conjunctival lymphoproliferative lesions were classified according to WHO classification: benign lymphoid hyperplasia in 7 patients, MALT-lymphoma in 7, and small B lymphocytic lymphoma in 4. Systemic lymphoma existed in 2 patients (11.1%). Remission was not achieved in one patients treated by surgical excision and chemotherapy. Complete remission was achieved in 5 patients with conjunctival malignant lymphoma treated by surgical excision, radiotherapy and chemotherapy. CONCLUSIONS: We consider that aggressive treatment using radiotherapy, chemotherapy and surgical excision in conjunctival malignant lymphoma is needful to achieve complete remission and prevent recurrence.
